On August 21, 2026, a clinical trial record update was posted for tirzepatide (LY3298176), an approved compound. The trial, titled "A Study of Tirzepatide (LY3298176) in Adult Participants in India With Either Type 2 Diabetes Mellitus or Obesity," is registered as NCT07438444.
The study is listed as Phase 4 and its current status is active, not recruiting. This means the trial is ongoing but is no longer enrolling new participants at this time.
The trial focuses on adult participants in India who have either type 2 diabetes mellitus or obesity. No results have been reported in this update, and no efficacy or safety outcomes are described at this stage.
This brief reflects only the status change reported as of the given date. Further updates to enrollment, completion, or results status may follow as the trial progresses. Readers interested in the compound can consult the tirzepatide overview for additional background and context on its approved uses and development history.